Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

Abstract

The threshold concentration for efficacy overlaps with concentrations at which toxicity occurs, although some toxicities increase over the entire Cτ range. Monitoring Cτ may optimise systemic exposure to improve clinical benefit and decrease the risk of certain adverse events.